Up-front temozolomide in elderly patients with glioblastoma (Q43199595)

15 November 2017

title

Up-front temozolomide in elderly patients with glioblastoma (English)

1 reference

Dominique Figarella-Branger

15 November 2017

0 references

2

object named as

Dominique Figarella-Branger

1 reference

15 November 2017

author name string

Florence Laigle-Donadey

1

1 reference

15 November 2017

Olivier Chinot

3

1 reference

15 November 2017

Luc Taillandier

4

1 reference

15 November 2017

Stéphanie Cartalat-Carel

5

1 reference

15 November 2017

Jérôme Honnorat

6

1 reference

15 November 2017

Gentian Kaloshi

7

1 reference

15 November 2017

Jean-Yves Delattre

8

1 reference

15 November 2017

Marc Sanson

9

1 reference

15 November 2017

publication date

8 January 2010

1 reference

Journal of Neuro-Oncology

15 November 2017

published in

1 reference

15 November 2017

volume

99

1 reference

15 November 2017

issue

1

1 reference

15 November 2017

page(s)

89-94

1 reference

Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patients

15 November 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-009-0110-3

A pilot study of primary temozolomide chemotherapy and deferred radiotherapy in elderly patients with glioblastoma

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/20058048

12 December 2020

Patterns of care and outcomes among elderly individuals with primary malignant astrocytoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20058048

12 December 2020

Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20058048

12 December 2020

Age as a predictive factor in glioblastomas: population-based study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20058048

12 December 2020

Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/20058048

12 December 2020

Short course of radiation therapy in elderly patients with glioblastoma multiforme

1 reference

https://pubmed.ncbi.nlm.nih.gov/20058048

12 December 2020

Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20058048

12 December 2020

Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide

1 reference

https://pubmed.ncbi.nlm.nih.gov/20058048

12 December 2020

Promoter Hypermethylation of the DNA Repair Gene O6‐Methylguanine‐DNA Methyltransferase is an Independent Predictor of Shortened Progression Free Survival in Patients with Low‐grade Diffuse Astrocytomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/20058048

12 December 2020

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20058048

12 December 2020

Radiotherapy for glioblastoma in the elderly.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20058048

12 December 2020

Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20058048

12 December 2020

Descriptive epidemiology of cerebral gliomas in France.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20058048

12 December 2020

Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations

1 reference

https://pubmed.ncbi.nlm.nih.gov/20058048

12 December 2020

MGMT prognostic impact on glioblastoma is dependent on therapeutic modalities

1 reference

https://pubmed.ncbi.nlm.nih.gov/20058048

12 December 2020

10.1007/S11060-009-0110-3

Identifiers

DOI

1 reference

Dimensions Publication ID

15 November 2017

1004606409

0 references

1 reference